Citation Impact
Citing Papers
The Pervasive Presence of Fluctuating Oxygenation in Tumors
2008
Immunotherapeutic Blockade of Macrophage Clever-1 Reactivates the CD8+ T-cell Response against Immunosuppressive Tumors
2019
Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
2014 Standout
Enhancement of chemotherapy by manipulation of tumour pH
1999
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia
2016 StandoutNobel
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
2021
Why do cancers have high aerobic glycolysis?
2004 Standout
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
2009 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors
2008
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Targeting hypoxia in cancer therapy
2011 Standout
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
2006 Standout
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
2015 Standout
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice
1997
Mutant p53 induces a hypoxia transcriptional program in gastric and esophageal adenocarcinoma
2019 StandoutNobel
Resistance of tumor cells to chemo- and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids
2001
Novel Imaging Provides New Insights into Mechanisms of Oxygen Transport in Tumors
2009
Drug penetration in solid tumours
2006 Standout
Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome
2008 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Acute versus chronic hypoxia in tumors
2012
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Is the hypoxia-inducible factor pathway important in gastric cancer?
2005
Intermittent Blood Flow in Solid Tumours – an under-appreciated Source of ‘drug Resistance’
2001
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era
2002
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Hypoxia Inhibits G1/S Transition through Regulation of p27 Expression
2001 StandoutNobel
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Can tumor angiogenesis be inhibited without resistance?
2005
Oxidative Stress in Cancer
2020 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling
2019
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
2002 StandoutNobel
The STATs of cancer — new molecular targets come of age
2004 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Tumor Angiogenesis
2008 Standout
The combined use of radiotherapy and chemotherapy in the treatment of solid tumours
2002
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Hypoxia-Inducible Factor 1 Regulates Vascular Endothelial Growth Factor Expression in Human Pancreatic Cancer
2003 StandoutNobel
Direct Assessment of Drug Penetration into Tissue Using a Novel Application of Three-Dimensional Cell Culture
2004
Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
2000 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Reactive oxygen species in the tumor niche triggers altered activation of macrophages and immunosuppression: Role of fluoxetine
2015
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Paclitaxel Decreases the Interstitial Fluid Pressure and Improves Oxygenation in Breast Cancers in Patients Treated With Neoadjuvant Chemotherapy: Clinical Implications
2005
Quantifying Transient Hypoxia in Human Tumor Xenografts by Flow Cytometry
2004
Diversity, Mechanisms, and Significance of Macrophage Plasticity
2019 Standout
Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
2001 StandoutNobel
Identification of nonproliferating but viable hypoxic tumor cells in vivo.
1998
Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent.
2003
Spontaneous Transformation of Cultured Mouse Bone Marrow–Derived Stromal Cells
2006 StandoutNobel
Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer.
2001
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Direct Demonstration of Instabilities in Oxygen Concentrations within the Extravascular Compartment of an Experimental Tumor
2006
Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.
1999
Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
2021
Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
2018
Review of methods used to study oxygen transport at the microcirculatory level
2000
Works of Nancy E. LePard being referenced
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs
2019
Contribution of Transient Blood Flow to Tumour Hypoxia in Mice
1995
Modulation of tumor hypoxia by conventional chemotherapeutic agents
1994
Tumour blood flow influences combined radiation and doxorubicin treatments
1997
Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice
2000
Maraviroc decreases CCL8-mediated migration of CCR5+regulatory T cells and reduces metastatic tumor growth in the lungs
2016
Macrophages Are More Potent Immune Suppressors Ex Vivo Than Immature Myeloid-Derived Suppressor Cells Induced by Metastatic Murine Mammary Carcinomas
2013